These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 18195165

  • 1. Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine.
    Tsukuda K, Mogi M, Li JM, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M.
    Hypertension; 2008 Feb; 51(2):528-33. PubMed ID: 18195165
    [Abstract] [Full Text] [Related]

  • 2. Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan.
    Tsukuda K, Mogi M, Li JM, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M.
    Hypertension; 2007 Dec; 50(6):1099-105. PubMed ID: 17968000
    [Abstract] [Full Text] [Related]

  • 3. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M, Kanno H, Inaba S, Senba I, Sone H, Nakaoka H, Horiuchi M.
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [Abstract] [Full Text] [Related]

  • 4. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M, Li HS, Chen R, Shiuchi T, Wu L, Min LJ, Li JM, Tsuda M, Suzuki J, Tomono Y, Tomochika H, Mogi M, Horiuchi M.
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice.
    Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M.
    Hypertension; 2009 Feb; 53(2):356-62. PubMed ID: 19047580
    [Abstract] [Full Text] [Related]

  • 13. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice.
    Itoh T, Kobayashi M, Horio F, Furuichi Y.
    Nutrition; 2009 Feb; 25(2):134-41. PubMed ID: 18929464
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Calcium channel blocker drugs and diabetic control.
    Collins WC, Cullen MJ, Feely J.
    Clin Pharmacol Ther; 1987 Oct; 42(4):420-3. PubMed ID: 3311549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus.
    Quevedo J, Vianna M, Daroit D, Born AG, Kuyven CR, Roesler R, Quillfeldt JA.
    Neurobiol Learn Mem; 1998 May; 69(3):320-5. PubMed ID: 9707493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.